NCLEX — Nicholas Limited Edition, Inc.
Data updated: 2026-05-26
NCLEX — Nicholas Limited Edition, Inc. data: holdings, portfolio allocation, expenses, performance, cashflows, risk and SEC filings. United States Small Cap Growth Equity · $329.71M AUM · 0.86% expense ratio · -10.2% 1-yr return. From SEC regulatory filings.
NCLEX Fund Overview
NCLEX — Nicholas Limited Edition, Inc. is a US mutual fund managed by NICHOLAS Ltd EDITION, INC., categorised as United States Small Cap Growth Equity. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US mutual fund
- Manager: NICHOLAS Ltd EDITION, INC.
- Category: United States Small Cap Growth Equity
- Assets under management: $329.71M
- 1-year return: -10.2%
- Ticker: NCLEX
- SEC CIK: 0000809802
- SEC series ID: S000009136
- Share class ID: C000024849
NCLEX Holdings
Top 10 holdings of Nicholas Limited Edition, Inc. by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets |
|---|---|
| Modine Manufacturing Company | 3.07% |
| Cohen & Steers, Inc. | 2.66% |
| Lattice Semiconductor Corp. | 2.65% |
| Prestige Consumer Healthcare, Inc. | 2.56% |
| Dorman Products, Inc. | 2.52% |
| Onto Innovation, Inc. | 2.41% |
| Encompass Health Corp. | 2.31% |
| Aptargroup, Inc. | 2.23% |
| Knight-Swift Transportation Holdings, Inc. | 2.23% |
| Descartes Systems Group, Inc. (the) | 2.19% |
NCLEX Portfolio Allocation
Asset-class allocation of Nicholas Limited Edition, Inc. by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 98.2% |
| Cash & Equivalents | 1.9% |
NCLEX Performance
Total returns for NCLEX (as of 2026-08-01), from SEC filings.
| Period | Total return |
|---|---|
| YTD | -8.0% |
| 1 year | -10.2% |
| 3 years (annualised) | 1.0% |
| 5 years (annualised) | -1.8% |
NCLEX Risk Information
Risk metrics for NCLEX, derived from monthly returns in SEC filings.
- 1-year volatility (annualised): 14.6%
NCLEX Costs and Fees
NCLEX costs about $86 per $10,000 invested per year in fund expenses.
- Net expense ratio: 0.86%
- Gross expense ratio: 0.86%
- Portfolio turnover: 14%
- Brokerage commissions: 4.32 bps of average net assets (SEC N-CEN)
NCLEX Cashflows
Over the 12 months to 2026-04, Nicholas Limited Edition, Inc. had net outflows of $45.36M, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2026-04 | −$8.37M |
| 2026-03 | −$4.36M |
| 2026-02 | −$5.87M |
| 2026-01 | −$5.84M |
| 2025-12 | $6.17M |
| 2025-11 | −$5.02M |
NCLEX Debt Constituents
No individual debt constituents are reported in Nicholas Limited Edition, Inc.'s latest SEC N-PORT filing.
NCLEX Prospectus and SEC Filings
Official Nicholas Limited Edition, Inc. filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
Related Funds
Other United States Small Cap Growth Equity funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.